ESC Premium Access

Hot Line - STOPDAPT-2 ACS

Event: ESC Congress 2021 - The Digital Experience
Topic: Interventional Cardiology
Session type: Hot Line
Date: 30 August 2021
Time: 18:25 - 18:55

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome

Speaker: Doctor H. Watanabe (Hirakata, JP)
Thumbnail

STOPDAPT-2 ACS - Discussant review.

Speaker: Professor R. Byrne (Dublin, IE)
Thumbnail

STOPDAPT-2 ACS - Panel discussion.

Thumbnail

2 speakers from this session

Doctor Hirotoshi Watanabe

Hirakata Kohsai Hospital, Hirakata (Japan)
1 presentation
1 follower

Professor Robert Byrne

Mater Private Network, Dublin (Ireland)
15 presentations
2 followers

Related content

ESC Premium Access

ESC Guidelines 2021 - Valvular Heart Disease

3 December 2021

ESC Premium Access

Personalized Approaches to antiplatelet treatment in ACS-PCI patients

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk